Trademark applications and grants for Dexcel Pharma Technologies L T D. Dexcel Pharma Technologies L T D has 27 trademark applications. The latest application filed is for "MELTECH"
Patent Application | Date |
---|---|
METHOD OF MANUFACTURING AN ORALLY DISINTIGRATING TABLET 20220125730 - 17/570548 MOSES-HELLER; Sheera ;   et al. | 2022-04-28 |
STABLE BENZIMIDAZOLE FORMULATION 20220031622 - 17/501237 PENHASI; Adel ;   et al. | 2022-02-03 |
ORALLY DISINTEGRATING COMPOSITIONS 20210353535 - 17/389612 MOSES-HELLER; Sheera | 2021-11-18 |
ALTERNATING AND SEMI-ALTERNATING POLY(ESTER-ANHYDRIDE) COPOLYMERS 20210009751 - 16/985399 DOMB; Abraham J. ;   et al. | 2021-01-14 |
METHODS FOR TREATING HELICOBACTER INFECTION 20200268769 - 16/066097 OREN; Dan | 2020-08-27 |
SEC | 0001720007 | Dexcel Pharma Technologies Ltd. of ISRAEL |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.